These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Systemic terbinafine treatment of dermatophytoses in children]. Wilmer A; Wollina U Mycoses; 1998; 41 Suppl 2():54-7. PubMed ID: 10085688 [TBL] [Abstract][Full Text] [Related]
23. Ajoene in the topical short-term treatment of tinea cruris and tinea corporis in humans. Randomized comparative study with terbinafine. Ledezma E; López JC; Marin P; Romero H; Ferrara G; De Sousa L; Jorquera A; Apitz Castro R Arzneimittelforschung; 1999 Jun; 49(6):544-7. PubMed ID: 10417874 [TBL] [Abstract][Full Text] [Related]
24. Acute generalized exanthematous pustulosis induced by terbinafine. Taberner R; Puig L; Gilaberte M; Alomar A Eur J Dermatol; 2003; 13(3):313-4. PubMed ID: 12805000 [TBL] [Abstract][Full Text] [Related]
25. [Failure of terbinafine treatment in 2 children with tinea capitis]. Strobos MA; Oranje AP Ned Tijdschr Geneeskd; 1996 Aug; 140(31):1611-2. PubMed ID: 8768817 [No Abstract] [Full Text] [Related]
26. Topical butenafine for tinea pedis. Med Lett Drugs Ther; 1997 Jul; 39(1004):63-4. PubMed ID: 9217695 [No Abstract] [Full Text] [Related]
27. Report of a case of a dermatophytoma successfully treated with topical efinaconazole 10% solution. Cantrell W; Canavan T; Elewski B J Drugs Dermatol; 2015 May; 14(5):524-6. PubMed ID: 25942674 [TBL] [Abstract][Full Text] [Related]
29. Fungicidal activity plus reservoir effect allow short treatment courses with terbinafine in tinea pedis. Schäfer-Korting M; Schoellmann C; Korting HC Skin Pharmacol Physiol; 2008; 21(4):203-10. PubMed ID: 18509254 [TBL] [Abstract][Full Text] [Related]
30. Clinical efficacy of terbinafine in 629 Japanese patients with dermatomycosis. Kagawa S Clin Exp Dermatol; 1989 Mar; 14(2):114-5. PubMed ID: 2689013 [No Abstract] [Full Text] [Related]
31. The use of oral terbinafine or topical ciclopirox for lichen planus. Click JW; Wilson BB Cutis; 2009 Jul; 84(1):42. PubMed ID: 19743723 [No Abstract] [Full Text] [Related]
32. A case of tinea barbae successfully treated with terbinafine. Tanuma H; Doi M; Nishiyama S; Katsuoka K Mycoses; 1998; 41(1-2):77-81. PubMed ID: 9610140 [TBL] [Abstract][Full Text] [Related]
33. A comparison of a new oral antifungal, terbinafine, with griseofulvin as therapy for tinea corporis. Cole GW; Stricklin G Arch Dermatol; 1989 Nov; 125(11):1537-9. PubMed ID: 2684023 [TBL] [Abstract][Full Text] [Related]
34. Allylamine antifungal drugs. Ryder NS; Mieth H Curr Top Med Mycol; 1992; 4():158-88. PubMed ID: 1732066 [No Abstract] [Full Text] [Related]
35. Combination treatment of oral terbinafine with topical terbinafine and 10% urea ointment in hyperkeratotic type tinea pedis. Shi TW; Zhang JA; Zhang XW; Yu HX; Tang YB; Yu JB Mycoses; 2014 Sep; 57(9):560-4. PubMed ID: 24697872 [TBL] [Abstract][Full Text] [Related]
36. The use of systemic antimycotics in dermatotherapy. Niewerth M; Korting HC Eur J Dermatol; 2000 Mar; 10(2):155-60. PubMed ID: 10694319 [TBL] [Abstract][Full Text] [Related]
37. Terbinafine. Shwayder T J Am Acad Dermatol; 1998 Jul; 39(1):136. PubMed ID: 9674414 [No Abstract] [Full Text] [Related]
38. Efficacy, tolerability and consumer acceptability of terbinafine topical spray versus terbinafine topical solution: a phase IIa, randomised, observer-blind, comparative study. Brown M; Evans C; Muddle A; Turner R; Lim S; Reed J; Traynor M Am J Clin Dermatol; 2013 Oct; 14(5):413-9. PubMed ID: 23740211 [TBL] [Abstract][Full Text] [Related]
39. Widespread tinea corporis in an immunocompetent patient resistant to all conventional forms of treatment. Vittorio CC Cutis; 1997 Dec; 60(6):283-5. PubMed ID: 9426967 [TBL] [Abstract][Full Text] [Related]
40. Role of oral antifungal agents for the treatment of superficial fungal infections in immunocompromised patients. Millikan LE Cutis; 2001 Jul; 68(1 Suppl):6-14. PubMed ID: 11499333 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]